Zhejiang Jingxin Pharmaceutical Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Zhejiang Jingxin Pharmaceutical Co., Ltd. (securities code: 002020) was established in 1990 and is a pharmaceutical listed company that integrates research and development, production, and sales. The company adheres to the business policy of "strengthening the pharmaceutical industry and developing medical devices", adheres to the core values of "pragmatism, innovation, inclusiveness, and win-win", and takes "meticulous care of health" as its mission. It is committed to becoming a leader in the fields of mental nerves, cardiovascular and cerebrovascular diseases in China. The company has two headquarters, Xinchang and Hangzhou, and has a Shanghai Research Institute located in the Zhangjiang High tech Park in Shanghai. It has six production bases and one traditional Chinese medicine raw material base, including Xinchang's preparation production base, Shangyu and Jiangxi Shangrao's raw material production base, Bayannur's traditional Chinese medicine production base in Inner Mongolia, medical device production bases in Shenzhen and Shenyang, and Yunnan's traditional Chinese medicine raw material base, And invest in the construction of Shandong Base and Jingxin Xinchang International Health Industry Park. Invest and cooperate in establishing companies and research and development laboratories in countries such as the United States, Israel, and South Korea. The company has always adhered to the quality concept of "Jingxin Drug, Carefully Made" and has fully passed the new version of GMP certification. The solid preparation production line rate passed the German GMP certification in 2006 and the on-site FDA certification in the United States in 2018. The comprehensive economic benefits of the company have rapidly improved, and for many consecutive years, it has been listed as one of the "Excellent Enterprise Brands for Exporting Chinese Chemical Pharmaceutical Industry Preparations", "Top 100 Chinese Pharmaceutical Industry", and "Top 100 Chinese Chemical Pharmaceutical Enterprises". It is the first batch of "Leading Enterprises for Internationalization of Chinese Pharmaceutical Enterprise Preparations", and one of the first batch of units to undertake outstanding scientific and technological projects for "Major New Drug Creation". Its social awareness and reputation are increasing day by day. The company is a national key high-tech enterprise, with a national enterprise technology center, a postdoctoral research workstation, a provincial key enterprise research institute, a provincial academician expert workstation, a provincial high-tech enterprise research and development center, a Shanghai Research Institute in Shanghai Zhangjiang High tech Park, and long-term cooperation with well-known research institutes and research and development companies at home and abroad, such as the Shanghai Institute of Pharmaceutical Industry, the Chinese Academy of Sciences Shanghai Institute of Organic Chemistry, Zhejiang University, As well as maintaining long-term good communication and cooperation relationships with renowned universities, possessing strong scientific and technological capabilities, achieving fruitful research and development results, possessing 8 national key new products, and undertaking 9 national torch program projects. As of June 30, 2021, the company has accumulated 173 valid patents, including 121 invention patents (114 domestic invention patents, 4 American invention patents, 1 European invention patent, 1 Japanese invention patent, and 1 Korean invention patent), 27 utility models, and 25 appearance designs, reflecting the company's strong research and development strength and innovation ability. |
| Headquarter | Shaoxing |
| Establish Date | 2/13/1999 |
| Listed Code | 002020.SZ |
| Listed Date | 7/15/2004 |
| Chairman | Lv Gang. |
| CEO | Lv Gang. |
| Website | www.jingxinpharm.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
